REVIEW 2 cited by
Stochastic Control of a SIR Model with Non-linear Incidence Rate Through Euclidean Path Integral
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
This paper utilizes a stochastic Susceptible-Infected-recovered (SIR) model with a non-linear incidence rate to perform a detailed mathematical study of optimal lock-down intensity and vaccination rate under the COVID-19 pandemic environment. We use a Feynman-type path integral control approach to determine a Fokker-Plank type equation of this system. Since we assume the availability of information on the COVID-19 pandemic is complete and perfect, we can show a unique fixed point. A non-linear incidence rate is used because, it can be raised from saturation effects that if the proportion of infected agents is very high so that exposure to the pandemic is inevitable, then the transmission rate responds slower than linearity to the increase in the number of infections. The simulation study shows that with higher diffusion coefficients susceptible and recovery curves keep the downward trends while the infection curve becomes ergodic. Finally, we perform a data analysis using UK data at the beginning of 2021 and compare it with our theoretical results.
Forward citations
Cited by 2 Pith papers
-
Exploring the Interplay of Adiposity, Ethnicity, and Hormone Receptor Profiles in Breast Cancer Subtypes
The paper reports higher BMI and Black race as predictors of Luminal B breast cancer with obesity as a partial mediator, but the evidence is a simulation with contradictory results.
-
Predictive Significance of CD276/B7-H3 Expression in Baseline Biopsies of Advanced Prostate Carcinoma
High B7-H3 expression in initial prostate biopsy samples is associated with shorter survival and more aggressive disease in men with advanced prostate cancer.
Discussion (0). Sign in to comment.